SANTA CLARA, California, March 7 /PRNewswire/ --

Finesse Solutions, LLC, a manufacturer of measurement and control
solutions for life sciences process applications, and Nova Biomedical,
Waltham, MA, a world leader in biotechnology process monitoring announced the
first TruBio(TM) OS plug-in for OPC connectivity between TruBio(TM) OS and
Nova BioProfile 400, 100 Plus, Basic 4 and Basic 2 analyzers. Both companies
confirmed that a TruBio(TM) OS plug-in for OPC connectivity to the Nova Flex
is currently in development.

OPC (Openness, Productivity and Collaboration) has become the de facto
standard for data exchange in process control systems. It has been adopted by
the majority of the control system manufacturers in the bioprocess industry
and has proven to be a reliable method for sharing information across
different hardware platforms.

Automatic data exchange using OPC between a lab analyzer and control
system reduces errors and time delays of manual sampling, and provides
automated reporting of results. It also allows the control system to adjust
process parameters without a 24/7 operator presence, and, in the event of
process alarm conditions, alerts off-site personnel and/or takes automatic
corrective action.

This level of integration enables direct consolidation of off-line lab
analyzer results into existing historical data collection, automates batch
report generation, and creates a complete electronic record. Printouts of
standalone analyzer results do not have to be manually attached or tracked
with electronic batch reports that control systems already provide.

"Taking advantage of OPC connectivity between Nova analyzers and the
Finesse bioprocess control system will improve quality and yield, while
reducing operating costs. For example, programming a Nova analyzer to
automatically standardize an in-situ probe, or using the resulting sample
data in real-time control algorithms, will increase both process
understanding and control accuracy," stated Dr. Mark Selker, CTO and
co-founder of Finesse.

"By redefining the standard associated with offline data to include
complete integration and the value of those data as they are applied to the
bioprocess automatically, Nova and Finesse continue to provide the cutting
edge technology required to bring the biotechnology industry into a new era
of effectiveness and profitability. The value lies in the actions upon that
information. Nova and Finesse provide the compliment to each other's
technologies thereby allowing our customers real-time benefits that, until
now, were impossible," says Bob Fox, Director of Sales.

About Finesse Solutions, LLC

California-based Finesse Solutions, LLC, leads the way in developing new
measurement and control technologies, in order to enable the transition to
single-use systems, bring new capabilities to existing bioreactor platforms,
and harmonize global bio-process information transfer. Our current product
family provides comprehensive measurement and control solutions for upstream
processes in the biotech and pharmaceutical industries. For more information,
please visit us at http://www.finesse.com.

About Nova Biomedical

Nova Biomedical is committed to continue its technology leadership with
advanced products that provide better, faster diagnostic information. We
continue to innovate biotechnology instruments that allow faster, more
economical development of drugs and other therapeutic products.

Web site: http://www.finesse.com